NewAmsterdam Pharma Company N.V. - Neraca (Quarterly)

NewAmsterdam Pharma Company N.V.

Talaan ng Balanse (Quarterly)

Neraca NewAmsterdam Pharma Company N.V. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
12-31
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
06-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 8 60 89 89 468 468 419 340 481 431 423 772 748 564
Change (%) 668.09 48.19 0.00 422.73 0.00 -10.49 -18.68 41.33 -10.48 -1.85 82.56 -3.02 -24.66
Assets Current 9 67 217 217 478 478 425 347 488 445 438 863 817 770
Change (%) 626.28 224.02 0.00 120.32 0.00 -11.09 -18.39 40.67 -8.71 -1.68 97.18 -5.34 -5.81
Assets 9 68 218 218 478 478 514 347 488 447 439 865 818 815
Change (%) 636.52 220.43 0.00 119.64 0.00 7.48 -32.51 40.73 -8.55 -1.68 96.87 -5.34 -0.40
Liabilities 13 11 33 33 48 48 53 59 77 59 60 107 41 37
Change (%) -11.29 194.24 0.00 44.86 0.00 10.08 10.11 30.59 -22.71 1.82 77.56 -61.68 -10.80
Equity -4 57 184 184 430 430 461 288 412 387 379 758 777 778
Change (%) -1,683.05 225.69 0.00 133.20 0.00 7.19 -37.44 42.79 -5.92 -2.21 99.94 2.62 0.15
Liabilities And Stock Equity 9 68 218 218 478 478 514 347 488 447 439 865 818 815
Change (%) 636.52 220.43 0.00 119.64 0.00 7.48 -32.51 40.73 -8.55 -1.68 96.87 -5.34 -0.40

Source: Capital IQ

Other Listings
DE:KH6
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista